Page last updated: 2024-08-22

zirconium and Neuroendocrine Tumors

zirconium has been researched along with Neuroendocrine Tumors in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Aggarwal, R; Ashworth, A; Badura, ML; Bailis, JM; Bidkar, AP; Chan, E; Chou, J; Cooke, KS; Delafontaine, B; Egusa, EA; Feng, FY; Flavell, RR; Hashemi Sadraei, N; Huang, J; Lee, F; Robinson, TM; Rottey, S; Salvati, M; Shenoy, T; Small, EJ; Steri, V; Stohr, BA; Trepka, K; Wang, S; Wang, Y; Yu, B; Zhu, J1
Bongaerts, AH; Brouwers, AH; de Jong, JR; de Vries, EG; Fiebrich, HB; Links, TP; Lub-de Hooge, MN; Oosting, SF; Oude Munnink, TH; Sluiter, WJ; van Asselt, SJ; Walenkamp, AM1
Abou, DS; Beattie, BJ; Carlin, SD; Lewis, JS; Pinkse, MW; Ramos, NN; Thorek, DL; Wolterbeek, HT1

Other Studies

3 other study(ies) available for zirconium and Neuroendocrine Tumors

ArticleYear
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.
    Cancer research, 2023, 01-18, Volume: 83, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Humans; Immunotherapy; Intracellular Signaling Peptides and Proteins; Ligands; Male; Membrane Proteins; Mice; Neuroendocrine Tumors; Positron-Emission Tomography; Prostatic Neoplasms; Zirconium

2023
Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:7

    Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Transport; Chromogranin A; Everolimus; Feasibility Studies; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Positron-Emission Tomography; Radioisotopes; Sirolimus; Treatment Outcome; Vascular Endothelial Growth Factor A; Zirconium

2014
(89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer.
    Pharmaceutical research, 2013, Volume: 30, Issue:3

    Topics: Animals; Cell Line, Tumor; Contrast Media; Gadolinium; Humans; Isotopes; Liposomes; Magnetic Resonance Imaging; Mice; Neuroendocrine Tumors; Octreotide; Positron-Emission Tomography; Receptors, Somatostatin; Zirconium

2013